Benjamin Margono

9.1k total citations · 2 hit papers
6 papers, 6.8k citations indexed

About

Benjamin Margono is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Health. According to data from OpenAlex, Benjamin Margono has authored 6 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 1 paper in Health. Recurrent topics in Benjamin Margono's work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Benjamin Margono is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Benjamin Margono collaborates with scholars based in Indonesia, China and Taiwan. Benjamin Margono's co-authors include Yi‐Long Wu, Tony Mok, Sumitra Thongprasert, Masahiro Fukuoka, Patrapim Sunpaweravong, Nagahiro Saijo, Yukito Ichinose, Yuichiro Ohe, James Chih‐Hsin Yang and Haiyi Jiang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Benjamin Margono

6 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

2009 6.4k citations Tony Mok, Yi‐Long Wu et al. New England Journal of Medicine profile →
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

2015 367 citations Tony Mok, Yi‐Long Wu et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Margono Indonesia	4	5.8k	4.5k	1.8k	1.7k	409	6	6.8k
Baohui Han China	8	5.5k 0.9×	4.3k 1.0×	1.5k 0.8×	1.7k 1.0×	357 0.9×	10	6.5k
Busyamas Chewaskulyong Thailand	7	5.5k 0.9×	4.3k 1.0×	1.5k 0.8×	1.7k 1.0×	355 0.9×	20	6.5k
Jin-Ji Yang China	10	6.6k 1.1×	5.1k 1.1×	1.8k 1.0×	2.0k 1.2×	417 1.0×	12	7.6k
Emma Duffield United Kingdom	13	7.2k 1.2×	5.7k 1.3×	2.1k 1.1×	2.1k 1.2×	442 1.1×	21	8.5k
Patrapim Sunpaweravong Thailand	16	7.1k 1.2×	5.7k 1.3×	1.9k 1.1×	2.2k 1.3×	455 1.1×	57	8.5k
Mircea Dediu Romania	19	5.1k 0.9×	4.8k 1.1×	894 0.5×	1.6k 0.9×	289 0.7×	55	6.6k
Serban Ghiorghiu United Kingdom	14	5.1k 0.9×	4.0k 0.9×	1.4k 0.7×	1.8k 1.0×	275 0.7×	30	5.9k
Eng Huat Tan Singapore	22	4.7k 0.8×	4.6k 1.0×	1.0k 0.6×	1.7k 1.0×	273 0.7×	55	6.8k
Sarayut Lucien Geater Thailand	21	5.3k 0.9×	4.6k 1.0×	1.1k 0.6×	1.6k 0.9×	247 0.6×	91	6.2k
Renato Martins United States	20	4.7k 0.8×	4.6k 1.0×	916 0.5×	1.7k 1.0×	302 0.7×	42	6.7k

Countries citing papers authored by Benjamin Margono

Since Specialization

Citations

This map shows the geographic impact of Benjamin Margono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Margono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Margono more than expected).

Fields of papers citing papers by Benjamin Margono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Margono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Margono. The network helps show where Benjamin Margono may publish in the future.

Co-authorship network of co-authors of Benjamin Margono

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Margono. A scholar is included among the top collaborators of Benjamin Margono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Margono. Benjamin Margono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Margono, Benjamin, et al.. (2019). Hubungan antara Obesitas dengan Penurunan Fungsi Faal Paru pada Polisi Wanita di Polda Jawa Timur. SHILAP Revista de lepidopterología. 1(1). 1–1. 2 indexed citations

2.

Wu, Yi‐Long, Nagahiro Saijo, Sumitra Thongprasert, et al.. (2016). Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC. Lung Cancer. 104. 119–125. 40 indexed citations

3.

Mok, Tony, Yi‐Long Wu, Jin Soo Lee, et al.. (2015). Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy. Clinical Cancer Research. 21(14). 3196–3203. 367 indexed citations breakdown →

4.

Peters, Madelon L., et al.. (2014). The Effect of Religiosity Mediated by Acceptance on Quality of Life: A Study on Muslim Patients with Cancer in Palliative Care. Data Archiving and Networked Services (DANS). 2 indexed citations

5.

Mok, Tony, Yi‐Long Wu, Sumitra Thongprasert, et al.. (2012). A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II.. Journal of Clinical Oncology. 30(15_suppl). 7519–7519. 21 indexed citations

6.

Mok, Tony, Yi‐Long Wu, Sumitra Thongprasert, et al.. (2009). Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma. New England Journal of Medicine. 361(10). 947–957. 6355 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact